Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
1170.85
Headquarter in London and 9 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 14 EP applications Hilary Mary van der Hoff has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12825651

PEG-INTERFERON LAMBDA 1 CONJUGATES

IPC classification:
C12P 21/04, C07K 11/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12833767

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/00, C12P 21/08, C07K 16/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12735490

IMMUNOCYTOKINE COMBINATION THERAPY

IPC classification:
A61K 47/48, A61K 38/20, C07K 16/18, C07K 14/54, C07K 14/525
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11875114

METHODS FOR TREATING HYPERURICEMIA IN PATIENTS WITH GOUT USING HALOFENATE OR HALOFENIC ACID AND A SECOND URATE-LOWERING AGENT

IPC classification:
A61K 31/19
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12864819

TAXANE AND ABEO-TAXANE ANALOGS

IPC classification:
A61K 31/357, A61K 31/335, A01N 43/52, C07D 309/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11875217

METHODS FOR TREATING GOUT FLARES

IPC classification:
A61K 31/20, A01N 37/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11875027

METHODS FOR TREATING GOUT IN PATIENT SUBPOPULATIONS

IPC classification:
A61K 31/20, A01N 37/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12850629

HUMAN NOTCH RECEPTOR MUTATIONS AND THEIR USE

IPC classification:
G01N 33/48, C07H 21/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12804651

ACID-LABILE LIPOPHILIC PRODRUGS OF CANCER CHEMOTHERAPEUTIC AGENTS

IPC classification:
A61K 47/44, A61K 31/265, C07D 317/24
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11807988

PHYTOPHTHORA RESISTANCE IN SWEET PEPPERS

IPC classification:
C12Q 1/68, A01H 5/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14166833

Metal delivery agents and terapeutic uses of the same

IPC classification:
A61K 33/34, A61K 33/30, A61K 31/555, A61K 31/315, A61K 31/30, A61K 31/28, A61K 31/145, A61P 35/00, A61P 31/00, A61P 25/00, A61P 9/00
Applicant:
University of Melbourne
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
The patent has been granted
EP12868058

CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS

IPC classification:
A61K 39/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12814264

RSPO BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 45/06, A61K 39/395, A61K 38/17, G01N 33/574, C07K 16/46, C07K 16/30, C07K 16/28, C07K 16/18, C07K 14/71, A61P 35/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14731098

BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)

IPC classification:
G01N 33/68
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Multiple attorneys, Olswang
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature